Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one of the nation's foremost pathology laboratories and largest independent ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation ...

Vista AI, Inc., the leader in automated MRI scanning software for hospitals and imaging centers, today announced the closing of $29.5 million in Series B financing. New investors include Cedars-Sinai ...

Stanford researchers have developed an AI that can predict future disease risk using data from just one night of sleep. The ...

With AI interpreting lab results for a growing number of patients, clinicians must provide context and caution and prepare ...

Minister Nolan Quinn visits Queen’s campus to announce $242 million in support of upgraded learning facilities and equipment at Ontario’s colleges and universities.

Scientists have developed an AI that can predict future disease risk using data from just one night of sleep. The system ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

Could our nightly sleep provide hidden clues to serious illnesses—years before symptoms appear? And could artificial ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...